日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Utilization of a Multi-modal Comprehensive Genomic and Immune Profiling Testing Strategy Results in a High Rate of Test Success and Detection of Clinically Relevant Biomarkers While Optimizing Tissue Usage

采用多模式综合基因组和免疫分析检测策略,可提高检测成功率,并能检测到具有临床意义的生物标志物,同时优化组织利用率。

Green, Michelle F; Wallen, Zachary D; Ko, Heidi C; Strickland, Kyle C; Dillard, Alicia; Conroy, Jeffrey M; Dash, Durga P; Nesline, Mary K; DePietro, Paul; Zhang, Shengle; Saini, Kamal S; Sathyan, Pratheesh; Eisenberg, Marcia; Caveney, Brian; Ramkissoon, Shakti; Severson, Eric A; Previs, Rebecca A

RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancer

RB1表达和HR功能是高级别浆液性卵巢癌预后不良亚型的标志。

Strickland, Kyle C; Wallen, Zachary D; Ko, Heidi C; Green, Michelle F; Dillard, Alicia; Pabla, Sarabjot; Hastings, Stephanie; Roos, Alison; Jensen, Taylor J; Eisenberg, Marcia; Caveney, Brian J; Ramkissoon, Shakti; Severson, Eric A; Previs, Rebecca A

Correction: RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancer

更正:RB1表达和HR功能正常定义了高级别浆液性卵巢癌的一种预后不良亚型。

Strickland, Kyle C; Wallen, Zachary D; Ko, Heidi C; Green, Michelle F; Dillard, Alicia; Pabla, Sarabjot; Hastings, Stephanie; Roos, Alison; Jensen, Taylor J; Eisenberg, Marcia; Caveney, Brian J; Ramkissoon, Shakti; Severson, Eric A; Previs, Rebecca A

Empowering patients for biomarker-informed care: digital education to bridge HER2-low knowledge gaps in metastatic breast cancer

赋能患者,使其能够基于生物标志物进行治疗:通过数字化教育弥合转移性乳腺癌中 HER2 低表达患者的知识差距

Ko, Heidi C; Patel, Stuti; Ellsworth, Rachel E; Green, Michelle F; Strickland, Kyle C; Rossi, Jenessa; Dua, Ashima; Said, Maya; Dossey, Amee Sato; Cuny, Carole; Dunn, Theresa; Weaner, Kimberly; Ramirez, Maria Celeste; Nelson, Cristina; Bohannon, Linda; Klein, Jonathan; Eisenberg, Marcia; Caveney, Brian; Severson, Eric A; Ramkissoon, Shakti; Previs, Rebecca A

Reference proteins to improve performance of core 1 and core 2 Alzheimer's disease CSF and plasma biomarkers

参考蛋白可提高阿尔茨海默病脑脊液和血浆生物标志物核心1和核心2的性能

Saini, Kamal S; Somara, Sasikala; Ko, Heidi C; Thatai, Purva; Quintana, Angela; Wallen, Zachary D; Green, Michelle F; Mehrotra, Ravi; McGuigan, Sandra; Pang, Lingjuan; Das, Soma; Yadav, Kavita; Neric, Dobrica; Cantini, Luca; Joshi, Chinmayee; Iwamoto, Kazuya; Dubbewar, Sudha; Vidal, Laura; Chico, Isagani; Severson, Eric; Lorini, Luigi; Badve, Sunil; Bossi, Paolo; Karlsson, Linda; Janelidze, Shorena; Barthélemy, Nicolas R; Horie, Kanta; Therriault, Joseph; Gaetani, Lorenzo; Bellomo, Giovanni; Schindler, Suzanne E; Vogel, Jacob W; Arvidsson, Ida; Åström, Kalle; Gordon, Brian A; Raji, Cyrus A; Benzinger, Tammie LS; Morris, John C; Nilsson, Johanna; Brinkmalm, Ann; Palmqvist, Sebastian; Stomrud, Erik; Salvadó, Gemma; Binette, Alexa Pichet; Filippo, Massimiliano Di; Parnetti, Lucilla; Rosa‐Neto, Pedro; Blennow, Kaj; Bateman, Randall J; Mattsson‐Carlgren, Niklas; Hansson, Oskar

Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast Cancer

免疫表型及其对HER2低表达与HER2零表达乳腺癌生存结局影响的综合评估

Ko, Heidi Chwan; Seager, R J; Pabla, Sarabjot; Senosain, Maria-Fernanda; Van Roey, Erik; Gao, Shuang; Strickland, Kyle C; Previs, Rebecca Ann; Green, Michelle F; Cooper, Maureen; Nesline, Mary K; Hastings, Stephanie B; Amoah, Kobina Agyaful; Zhang, Shengle; Conroy, Jeffrey M; Jensen, Taylor J; Eisenberg, Marcia; Caveney, Brian; Severson, Eric A; Ramkissoon, Shakti; Gandhi, Shipra

Association of Race and Ethnicity with Genomic Testing at a Comprehensive Cancer Center in North Carolina

北卡罗来纳州一家综合癌症中心的种族和民族与基因组检测的关联

Meernik, Clare; Wang, Frances; Raveendran, Yadurshini; Green, Michelle F; Check, Devon K; Bosworth, Hayden B; Sutton, Linda M; Strickler, John H; Akinyemiju, Tomi F

Comprehensive Genomic Profiling in Non-Myeloid Hematologic Malignancies Identifies Variants That Can Alter Clinical Practice

非髓系血液恶性肿瘤的全面基因组分析可识别出能够改变临床实践的变异

Lin, Chenyu; Zhou, Katherine I; Green, Michelle F; Caughey, Bennett A; Strickler, John H; Datto, Michael B; McKinney, Matthew S

Concordance Between Genomic Alterations Detected by Tumor and Germline Sequencing: Results from a Tertiary Care Academic Center Molecular Tumor Board

肿瘤测序和种系测序检测到的基因组改变的一致性:来自三级学术中心分子肿瘤委员会的结果

Green, Michelle F; Watson, Catherine H; Tait, Sarah; He, Jie; Pavlick, Dean C; Frampton, Garrett; Riedel, Jinny; Plichta, Jennifer K; Armstrong, Andrew J; Previs, Rebecca A; Kauff, Noah; Strickler, John H; Datto, Michael B; Berchuck, Andrew; Menendez, Carolyn S

Identification of an optimal mutant allele frequency to detect activating KRAS, NRAS, and BRAF mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas

在商业化的无细胞DNA下一代测序检测方法中,确定检测结直肠癌和胰腺腺癌中KRAS、NRAS和BRAF激活突变的最佳突变等位基因频率

Caughey, Bennett A; Umemoto, Kumiko; Green, Michelle F; Ikeda, Masafumi; Lowe, Melissa E; Ueno, Makoto; Niedzwiecki, Donna; Taniguchi, Hiroya; Walden, Daniel J; Komatsu, Yoshito; D'Anna, Rachel; Esaki, Taito; Denda, Tadamichi; Datto, Michael B; Bando, Hideaki; Bekaii-Saab, Tanios; Yoshino, Takayuki; Strickler, John H; Nakamura, Yoshiaki